AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer
Authors: Adachi, S Itani, Y Ito, K Noda, T Shintani, M Saito, K Furukawa, N Tomii, Y
Citation: S. Adachi et al., Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer, ONCOL REP, 8(1), 2001, pp. 27-31
Sequence analysis of candidate genes for common susceptibility to type 1 and type 2 diabetes in mice
Authors: Yamada, K Ikegami, H Kawaguchi, Y Fujisawa, T Hotta, M Ueda, H Shintani, M Nojima, K Kawabata, Y Ono, M Nishino, M Itoi, M Babaya, N Shibata, M Makino, S Ogihara, T
Citation: K. Yamada et al., Sequence analysis of candidate genes for common susceptibility to type 1 and type 2 diabetes in mice, ENDOCR J, 48(2), 2001, pp. 241-247
Lack of association between hepatocyte nuclear factor-1 beta gene and common forms of Type 2 diabetes in the Japanese population
Authors: Babaya, N Ikegami, H Fujisawa, T Hotta, M Ueda, H Shintani, M Nojima, K Kawabata, Y Ono, M Nishino, M Itoi-Babaya, M Taniguchi, H Noso, S Horiki, M Yamada, K Kawaguchi, Y Fukuda, M Ogihara, T
Citation: N. Babaya et al., Lack of association between hepatocyte nuclear factor-1 beta gene and common forms of Type 2 diabetes in the Japanese population, DIABET NUTR, 14(4), 2001, pp. 220-224
A simple cointegrating rank test without vector autoregression
Authors: Shintani, M
Citation: M. Shintani, A simple cointegrating rank test without vector autoregression, J ECONOMET, 105(2), 2001, pp. 337-362
Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects
Authors: Nishino, M Ikegami, H Kawaguchi, Y Fujisawa, T Kawabata, Y Shintani, M Ono, M Horiki, M Kawasaki, E Ogihara, T
Citation: M. Nishino et al., Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects, HUMAN IMMUN, 62(5), 2001, pp. 518-522
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. (vol 50, pg 1440, 2001)
Authors: Ebihara, K Ogawa, Y Masuzaki, H Shintani, M Miyanaga, F Aizawa-Abe, M Hayashi, T Hosoda, K Inoue, G Yoshimasa, Y Gavrilova, O Reitman, ML Nakao, K
Citation: K. Ebihara et al., Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. (vol 50, pg 1440, 2001), DIABETES, 50(7), 2001, pp. 1675-1675
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
Authors: Ebihara, K Ogawa, Y Masuzaki, H Shintani, M Miyanaga, F Aizawa-Abe, M Hayashi, T Hosoda, K Inoue, G Yoshimasa, Y Gavrilova, O Reitman, ML Nakao, K
Citation: K. Ebihara et al., Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes, DIABETES, 50(6), 2001, pp. 1440-1448
Troglitazone induces GLUT4 translocation in L6 myotubes
Authors: Yonemitsu, S Nishimura, H Shintani, M Inoue, R Yamamoto, Y Masuzaki, H Ogawa, Y Hosoda, K Inoue, G Hayashi, T Nakao, K
Citation: S. Yonemitsu et al., Troglitazone induces GLUT4 translocation in L6 myotubes, DIABETES, 50(5), 2001, pp. 1093-1101
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway
Authors: Shintani, M Ogawa, Y Ebihara, K Aizawa-Abe, M Miyanaga, F Takaya, K Hayashi, T Inoue, G Hosoda, K Kojima, M Kangawa, K Nakao, K
Citation: M. Shintani et al., Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway, DIABETES, 50(2), 2001, pp. 227-232
Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes
Authors: Shintani, M Nishimura, H Yonemitsu, S Ogawa, Y Hayashi, T Hosoda, K Inoue, G Nakao, K
Citation: M. Shintani et al., Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes, DIABETES, 50(10), 2001, pp. 2296-2300
Genetic polymorphisms and functional characterization of the 5 '-flanking region of the human CYP2C9 gene: In vitro and in vivo studies
Authors: Shintani, M Ieiri, I Inoue, K Mamiya, K Ninomiya, H Tashiro, N Higuchi, S Otsubo, K
Citation: M. Shintani et al., Genetic polymorphisms and functional characterization of the 5 '-flanking region of the human CYP2C9 gene: In vitro and in vivo studies, CLIN PHARM, 70(2), 2001, pp. 175-182
Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus
Authors: Kawabata, Y Ikegami, H Kawaguchi, Y Fujisawa, T Hotta, M Ueda, H Shintani, M Nojima, K Ono, M Nishino, M Taniguchi, H Noso, S Yamada, K Babaya, N Ogihara, T
Citation: Y. Kawabata et al., Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus, HUMAN IMMUN, 61(6), 2000, pp. 624-629
Downregulation of leptin by free fatty acids in rat adipocytes: Effects oftriacsin C, palmitate, and 2-bromopalmitate
Authors: Shintani, M Nishimura, H Yonemitsu, S Masuzaki, H Ogawa, Y Hosoda, K Inoue, G Yoshimasa, Y Makao, K
Citation: M. Shintani et al., Downregulation of leptin by free fatty acids in rat adipocytes: Effects oftriacsin C, palmitate, and 2-bromopalmitate, METABOLISM, 49(3), 2000, pp. 326-330
Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere
Authors: Mimoto, T Hattori, N Takaku, H Kisanuki, S Fukazawa, T Terashima, K Kato, R Nojima, S Misawa, S Ueno, T Imai, J Enomoto, H Tanaka, S Sakikawa, H Shintani, M Hayashi, H Kiso, Y
Citation: T. Mimoto et al., Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere, CHEM PHARM, 48(9), 2000, pp. 1310-1326
Comparative evaluation of conjugate vaccines in the Haemophilus influenzaeinfection model
Authors: Miyazaki, S Shintani, M Matsumoto, T Tateda, K Yamaguchi, K
Citation: S. Miyazaki et al., Comparative evaluation of conjugate vaccines in the Haemophilus influenzaeinfection model, CAN J MICRO, 46(4), 2000, pp. 358-362
Study on cavitation damage characteristics around a hollow-jet valve
Authors: Wang, GY Liu, SJ Shintani, M Ikohagi, T
Citation: Gy. Wang et al., Study on cavitation damage characteristics around a hollow-jet valve, JSME I J B, 42(4), 1999, pp. 649-657
A phase I study of cisplatin ip and carboplatin iv with G-CSF in patients with ovarian cancer
Authors: Adachi, S Ito, K Itani, Y Noda, T Shintani, M Kawai, S Beppu, K Ito, A Saito, K Hisanaga, H Fukumoto, Y Tomii, Y Masuda, M
Citation: S. Adachi et al., A phase I study of cisplatin ip and carboplatin iv with G-CSF in patients with ovarian cancer, ONCOL REP, 6(2), 1999, pp. 311-315
Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus
Authors: Fujisawa, T Ikegami, H Yamato, E Kawaguchi, Y Ueda, H Shintani, M Nojima, K Kawabata, Y Ono, M Nishino, T Noso, S Yamada, K Babaya, N Okamoto, N Ohguro, N Fukuda, M Ogihara, T
Citation: T. Fujisawa et al., Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus, DIABET MED, 16(6), 1999, pp. 522-526
A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies
Authors: Ito, K Adachi, S Itani, Y Koyama, M Hori, K Chin, R Shintani, M Beppu, K Kawai, S Saito, K
Citation: K. Ito et al., A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies, JPN J CLIN, 29(6), 1999, pp. 299-302
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection
Authors: Humphrey, RW Wyvill, KM Nguyen, BY Shay, LE Kohler, DR Steinberg, SM Ueno, T Fukasawa, T Shintani, M Hayashi, H Mitsuya, H Yarchoan, R
Citation: Rw. Humphrey et al., A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection, ANTIVIR RES, 41(1), 1999, pp. 21-33
Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol
Authors: Fujisawa, T Ikegami, H Tsutsui, T Kawaguchi, Y Ueda, H Shintani, M Nojima, K Kawabata, Y Ono, M Nishino, M Noso, S Yamada, K Babaya, N Ogihara, T
Citation: T. Fujisawa et al., Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol, DIABET CARE, 22(5), 1999, pp. 863-864
Abnormal blinking of newscasters
Authors: Tsubota, K Egami, F Ohtsuki, T Shintani, M
Citation: K. Tsubota et al., Abnormal blinking of newscasters, LANCET, 354(9175), 1999, pp. 308-308
JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1
Authors: Yoshimura, K Kato, R Yusa, K Kavlick, MF Maroun, V Nguyen, A Mimoto, T Ueno, T Shintani, M Falloon, J Masur, H Hayashi, H Erickson, J Mitsuya, H
Citation: K. Yoshimura et al., JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1, P NAS US, 96(15), 1999, pp. 8675-8680
Thyrotropin decreases leptin production in rat adipocytes
Authors: Shintani, M Nishimura, H Akamizu, T Yonemitsu, S Masuzaki, H Ogawa, Y Hosoda, K Inoue, G Yoshimasa, Y Nakao, K
Citation: M. Shintani et al., Thyrotropin decreases leptin production in rat adipocytes, METABOLISM, 48(12), 1999, pp. 1570-1574
Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine
Authors: Mimoto, T Kato, R Takaku, H Nojima, S Terashima, K Misawa, S Fukazawa, T Ueno, T Sato, H Shintani, M Kiso, Y Hayashi, H
Citation: T. Mimoto et al., Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine, J MED CHEM, 42(10), 1999, pp. 1789-1802
Risultati: 1-25 | 26-26